We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Biomarkers.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Biomarkers - List of Manufacturers, Suppliers, Companies and Products

Biomarkers Product List

1～7 item / All 7 items

Displayed results
[Research Material] Global Market for Stroke Biomarkers

[Research Material] Global Market for Stroke Biomarkers

Global Market for Stroke Biomarkers: Blood Biomarkers, Urine Biomarkers, Diagnostics, Drug Development, Personalized Medicine, and Others

This research report (Global Stroke Testing Biomarkers Market) investigates and analyzes the current status and outlook for the global market of stroke testing biomarkers over the next five years. It includes information on the overview of the global stroke testing biomarkers market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include blood biomarkers and urine biomarkers, while the segments by application cover diagnosis, drug development, personalized medicine, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of stroke testing biomarkers. It also includes the market share of major companies in the stroke testing biomarkers sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Diagnostic Exosome Biomarkers

[Research Material] Global Market for Diagnostic Exosome Biomarkers

World Market for Diagnostic Exosome Biomarkers: Membrane-Bound Proteins, Soluble Proteins, Non-Coding RNA, Others, Hospitals, C...

This research report (Global Diagnostic Exosome Biomarker Market) investigates and analyzes the current status and outlook for the global market of diagnostic exosome biomarkers over the next five years. It includes information on the overview of the global diagnostic exosome biomarker market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the diagnostic exosome biomarker market include membrane-bound proteins, soluble proteins, non-coding RNA, and others, while the segments by application focus on hospitals, clinics, and outpatient surgery centers. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of diagnostic exosome biomarkers. The report also includes the market share of major companies in the diagnostic exosome biomarker sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Diagnostic Biomarkers

[Research Material] Global Market for Diagnostic Biomarkers

Global Market for Diagnostic Biomarkers: Safety Biomarkers, Efficacy Biomarkers, Verification Biomarkers, Hospitals, Cancer Research Institutes, Diagnostic Research Institutes

This research report (Global Diagnostic Biomarkers Market) investigates and analyzes the current state and future outlook of the global diagnostic biomarkers market over the next five years. It includes information on the overview of the global diagnostic biomarkers market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the diagnostic biomarkers market focus on safety biomarkers, efficacy biomarkers, and verification biomarkers, while the segments by application target hospitals, cancer research institutes, and diagnostic research laboratories. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for diagnostic biomarkers. It also includes the market share of major companies in the diagnostic biomarkers sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Cancer Biomarkers

[Market Report] Global Market for Cancer Biomarkers

The global market for cancer biomarkers is expected to achieve significant growth, surpassing 36.2 billion USD by 2031, with an average annual growth rate of 13%.

The global cancer biomarker market is experiencing remarkable growth driven by advancements in personalized medicine, early detection technologies, and increasing attention to precision oncology. The market size in 2022 was 12.7 billion USD, and this dynamic market is expected to expand significantly, exceeding 36.2 billion USD by 2031. This growth is projected to be supported by a robust compound annual growth rate (CAGR) of 13% during the forecast period from 2023 to 2031. Cancer biomarkers have emerged as essential tools that enhance the accuracy of cancer diagnosis, prognosis, and treatment selection. These molecular indicators provide valuable insights into the patient-specific genetic makeup, enabling healthcare professionals to develop tailored treatment strategies that improve outcomes and reduce side effects. Please check the application method via the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Neurobiomarkers

[Market Report] Global Market for Neurobiomarkers

The global market for neuro biomarkers is expected to surge, reaching 22.1 billion USD by 2031.

The global neurological biomarker market is experiencing significant rapid growth and is expected to see substantial expansion in the coming years. In 2022, the market achieved revenues of approximately 7.39 billion USD. It is projected to reach 22.1 billion USD by 2031, indicating a strong outlook for market expansion. This robust growth trajectory is supported by a steady compound annual growth rate (CAGR) of 13% during the forecast period from 2023 to 2031. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.